M&A Deal Summary

Bionomics Acquires Prestwick Chemical

On September 23, 2014, Bionomics acquired life science company Prestwick Chemical for 270M EUR

Acquisition Highlights
  • This is Bionomics’ 3rd transaction in the Life Science sector.
  • This is Bionomics’ 0th largest (disclosed) transaction.
  • This is Bionomics’ 2nd transaction in France.
Investment Fate
  • Prestwick Chemical was divested to a consortium of strategic buyers in 2019.

M&A Deal Summary
Date 2014-09-23
Target Prestwick Chemical
Sector Life Science
Buyer(s) Bionomics
Deal Type Add-on Acquisition
Deal Value 270M EUR

Target

Prestwick Chemical

Illkirch, France
Prestwick Chemical, Inc. is a provider of medicinal chemistry services and smart screening libraries. The company specializes in research and development services in early drug discovery including hit identification and validation, hit to lead, and lead optimization based on its expertise and state-of-the-art computational technology. Prestwick Chemical was formed in 1999 and is based in Illkirch, France.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bionomics

Eastwood, Australia
Category Company
Founded 1996
Sector Life Science
Revenue 4M AUD (2019)
DESCRIPTION

Bionomics is a biopharmaceutical company dedicated to making better treatments for cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. Bionomics was founded in 1996 and is headquartered in Eastwood ,Australia.

DEAL STATS #
Overall 3 of 3
Sector (Life Science) 3 of 3
Type (Add-on Acquisition) 3 of 3
Country (France) 2 of 2
Year (2014) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-09-17 Eclipse Therapeutics

San Diego, California, United States

Eclipse Therapeutics, Inc., a biotechnology company, engages in the discovery and development of therapeutic antibodies that target cancer stem cells and other forms of cancer treatment.

Buy $10M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-11 Prestwick Chemical

Illkirch, France

Prestwick Chemical, Inc. is a provider of medicinal chemistry services and smart screening libraries. The company specializes in research and development services in early drug discovery including hit identification and validation, hit to lead, and lead optimization based on its expertise and state-of-the-art computational technology. Prestwick Chemical was formed in 1999 and is based in Illkirch, France.

Sell -
Mergr

Product

Company

Legal